Evaluation of efficacy and safety of Qiangzhu-qinggan formula as an adjunctive therapy in adult patients with severe influenza: study protocol for a randomized parallel placebo-controlled double-blind multicenter trial

BACKGROUND: Influenza can fall into three categories according to severity: mild influenza, severe influenza, and critical influenza. Severe influenza can result in critical illness and sometimes death particularly in patients with comorbidities, advanced age, or pregnancy. Neuraminidase inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Lei, Wu, Xian-wei, Zhang, Shao-yan, Yang, Ming, Zhang, Shun-xian, Fu, Ji-you, Li, Cui, Zhang, Zhi-jie, Zheng, Pei-yong, Lu, Zhen-hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710932/
https://www.ncbi.nlm.nih.gov/pubmed/34961550
http://dx.doi.org/10.1186/s13063-021-05929-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710932/
https://www.ncbi.nlm.nih.gov/pubmed/34961550
http://dx.doi.org/10.1186/s13063-021-05929-8

Ejemplares similares